BackDelMar Pharmaceuticals Overview

DelMar Pharmaceuticals Current Cash

DelMar Pharmaceuticals's current cash is $1.9M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.89M
↓ 29.77% YoYΔ $-803065.00 vs prior year quarter

Peer trimmed avg / median

Loading

DelMar Pharmaceuticals Current Cash History

Loading

DelMar Pharmaceuticals vs. peers: Current Cash Comparison

Loading

DelMar Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DelMar Pharmaceuticals (DMPWW) FAQ

DelMar Pharmaceuticals's current cash stands at $1.9M as of September 2026. That compares with $2.7M in the prior-year period — down 29.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

DelMar Pharmaceuticals reported $1.9M in current cash versus $2.7M a year earlier — a 29.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $2.7M in the prior-year period — down 29.8% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how DelMar Pharmaceuticals's current cash evolved across reporting periods, while the comparison chart places DMPWW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Materials, current cash is commonly used to spot outliers. DelMar Pharmaceuticals's reading of $1.9M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.